
Sign up to save your podcasts
Or


We saw the amazing performance of Pfizer and Moderna's two mRNA COVID vaccines in their RCTs. As encouraging as trial performance is, we always want to know how those numbers hold up under large-scale, real-world pragmatic conditions. Well, we now have three new pieces of information on that. And, for the cherry on top, we get evidence of performance against asymptomatic infection! Dr. Jarvis does a quick review of the latest evidence on vaccine performance.
By Long Pause Media | FlightBridgeED4.9
131131 ratings
We saw the amazing performance of Pfizer and Moderna's two mRNA COVID vaccines in their RCTs. As encouraging as trial performance is, we always want to know how those numbers hold up under large-scale, real-world pragmatic conditions. Well, we now have three new pieces of information on that. And, for the cherry on top, we get evidence of performance against asymptomatic infection! Dr. Jarvis does a quick review of the latest evidence on vaccine performance.

125 Listeners

1,875 Listeners

384 Listeners

21 Listeners

96 Listeners

228 Listeners

264 Listeners

272 Listeners

42 Listeners

148 Listeners

42 Listeners

19 Listeners

889 Listeners

213 Listeners

8 Listeners